We are live on ! Find out more
DS

Dudley & Shanley Portfolio holdings

AUM $662M
1-Year Est. Return 10.7%
This Fund
S&P 500
This Quarter Est. Return
-0.22%
1 Year Est. Return
+10.7%
3 Year Est. Return
+57.04%
5 Year Est. Return
+90.57%
10 Year Est. Return
+304.94%
AUM
$582M
AUM Growth
-$10.7M
Cap. Flow
-$3.26M
Cap. Flow %
-0.56%
Top 10 Hldgs %
55.6%
Holding
37
New
1
Increased
8
Reduced
20
Closed
1

Top Buys

Rank Stock Value
1
ADI icon
Analog Devices
ADI
+$5.61M
2
SCHW
Charles Schwab
SCHW
+$3.46M
3
WST icon
West Pharmaceutical
WST
+$2.88M
4
KRNT icon
Kornit Digital
KRNT
+$828K
5
KAI icon
Kadant
KAI
+$492K

Top Sells

Rank Stock Value
1
PGR icon
Progressive
PGR
+$5.15M
2
DOX icon
Amdocs
DOX
+$1.63M
3
WPM icon
Wheaton Precious Metals
WPM
+$1.51M
4
FELE icon
Franklin Electric
FELE
+$884K
5
FISV
Fiserv Inc
FISV
+$724K

Sector Composition

Rank Sector Weight
1 Financials 20.73%
2 Technology 20%
3 Materials 17.17%
4 Healthcare 12.63%
5 Consumer Discretionary 11.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HEI icon
26
HEICO Corp
HEI
$47.9B
$4.37M 0.75%
19,550
+1,150
+6% +$243K
KAI icon
27
Kadant
KAI
$3.67B
$3.22M 0.55%
10,955
+1,725
+19% +$492K
GNRC icon
28
Generac Holdings
GNRC
$12.7B
$3.17M 0.54%
23,950
KRNT icon
29
Kornit Digital
KRNT
$696M
$3.03M 0.52%
207,100
+53,700
+35% +$828K
ENPH icon
30
Enphase Energy
ENPH
$5.48B
$2.6M 0.45%
26,030
+4,130
+19% +$481K
ORA icon
31
Ormat Technologies
ORA
$6.43B
$2.22M 0.38%
30,900
-5,500
-15% -$382K
PHO icon
32
Invesco Water Resources ETF
PHO
$1.99B
$2.13M 0.37%
32,780
ROP icon
33
Roper Technologies
ROP
$36.6B
$1.44M 0.25%
2,550
DCI icon
34
Donaldson
DCI
$10.5B
$369K 0.06%
5,150
+1,400
+37% +$103K
OCUL icon
35
Ocular Therapeutix
OCUL
$1.96B
$111K 0.02%
+16,200
New +$100K
IRDM icon
36
Iridium Communications
IRDM
$4.95B
-14,000
Closed -$366K

Similar funds

Dudley & Shanley's Q2 2024 Portfolio in Review

As of Q2 2024, Dudley & Shanley held 37 positions worth $582M, down 1.8% from $593M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Dudley & Shanley's Q2 2024 filing shows 1 new, 8 increased, 20 reduced and 1 closed positions. Its largest new stake was Ocular Therapeutix: 16,200 shares worth $111K. The largest sale was Progressive, an estimated $5.15M.

By sector, the portfolio is most concentrated in Financials at 21% of assets, down from 22% a quarter earlier, followed by Technology and Materials.

  • Dudley & Shanley's largest Q2 2024 buy was Ocular Therapeutix: 16,200 shares worth $111K.
  • Dudley & Shanley added most to Analog Devices in Q2 2024, an estimated $5.61M increase.
  • Dudley & Shanley's biggest Q2 2024 reduction was Progressive, cutting an estimated $5.15M.
  • Dudley & Shanley fully exited Iridium Communications in Q2 2024, selling an estimated $366K.
  • Dudley & Shanley's ten largest holdings make up 56% of its $582M portfolio in Q2 2024.
  • Dudley & Shanley opened 1 new position and closed 1 in Q2 2024.
  • Dudley & Shanley's portfolio value fell 1.8% quarter-over-quarter to $582M.

Based on Dudley & Shanley's 13F filing for Q2 2024, filed 9 Jul 2024.